"O Hospital da Bahia inaugurado em 20 de Janeiro de 2006, foi planejado para atender aos novos conceitos de assistência à saúde. A partir de sua concepção o complexo hospitalar passou a integrar física e virtualmente por meio de avançado sistema de tecnologia de informatica, um moderno Centro Médico, Centro de Diagnóstico por Imagem, Medicina Laboratorial e Unidades de Internação. Agrega ao arrojado projeto arquitetônico tecnologia de ponta na área de diagnóstico e de informática com utilização do prontuário eletrônico. O hospital tem ainda como escopo básico de sua assistência o acolhimento de pacientes de forma humanizada."

During the past decade, Hospital da Bahia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital da Bahia" #1 sponsor was "Pfizer" with 4 trials, followed by "Hospital Alemão Oswaldo Cruz" with 1 trials sponsored, "Hospital do Coracao" with 1 trials sponsored, "NYU Langone Health" with 1 trials sponsored and "SENAI CIMATEC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital da Bahia" #1 collaborator was "Hospital Israelita Albert Einstein" with 2 trials as a collaborator, "Hospital Moinhos de Vento" with 2 trials as a collaborator, "A Beneficência Portuguesa de São Paulo" with 1 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator and "Brazilian Research In Intensive Care Network" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Hospital da Bahia" are "Cardiovascular Disease" (2 trials), "COVID-19" (1 trials), "Cardiovascular Diseases" (1 trials), "Catheter-Associated Urinary Tract Infection" (1 trials) and "Central Line-associated Bloodstream Infection (CLABSI)" (1 trials). Many other conditions were trialed in "Hospital da Bahia" in a lesser frequency.

Most popular intervention types in "Hospital da Bahia" are "Drug" (4 trials), "Biological" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "2% chlorhexidine digluconate solution with surface-active agents" (1 trials), "Avelumab" (1 trials) and "Best Supportive Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital da Bahia" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Hospital da Bahia". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital da Bahia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital da Bahia, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".